Nishio, Makoto
Murakami, Haruyasu
Ohe, Yuichiro
Hida, Toyoaki
Sakai, Hiroshi
Kasahara, Kazuo
Imamura, Fumio
Baba, Tomohisa
Kubota, Kaoru
Hosomi, Yukio
Shimokawa, Tsuneo
Hayashi, Hidetoshi
Miyadera, Kazutaka
Tamura, Tomohide
Article History
Received: 4 December 2018
Accepted: 16 January 2019
First Online: 21 February 2019
Compliance with ethical standards
:
: Makoto Nishio has received grants and/or honoraria for speakers bureau from Astellas, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai Pharmaceutical, Eli Lilly, MSD, Novartis, Ono Pharmaceutical, Pfizer, and Taiho Pharmaceutical.Haruyasu Murakami has received honoraria for speakers bureau from AstraZeneca and Chugai Pharmaceutical.Yuichiro Ohe has received grants and/or honoraria for speakers bureau from AstraZeneca; Bayer; Bristol-Myers Squibb; Boehringer Ingelheim; Chugai Pharmaceutical; Daiichi Sankyo; Dainippon-Sumitomo; Ignyta; Japan Agency for Medical Research and Development; Kyorin; Eli Lilly; Ministry of Health, Labour and Welfare; MSD; Nipponkayaku; Novartis; Pfizer; and Taiho Pharmaceutical; and has worked as a consultant for AstraZeneca, Chugai Pharmaceutical, and Eli Lilly.Toyoaki Hida has received grants and/or honoraria for speakers bureau from Astellas, AstraZeneca, Clovis Oncology, Novartis, and Taiho Pharmaceutical.Hiroshi Sakai has received honoraria for speakers bureau from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, MSD, Ono Pharmaceutical, and Taiho Pharmaceutical.Kazuo Kasahara has received grants from Boehringer Ingelheim and honoraria for speakers bureau from AstraZeneca, Boehringer Ingelheim, Chugai Pharmaceutical, and Taiho Pharmaceutical.Fumio Imamura has received grants and honoraria for speakers bureau from AstraZeneca, Boehringer Ingelheim, Chugai Pharmaceutical, and Taiho Pharmaceutical.Tomohisa Baba has received honoraria for speakers bureau from AstraZeneca, Nippon Boehringer Ingelheim, and Taiho Pharmaceutical, and has worked as a consultant for AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, and Ono Pharmaceutical.Kaoru Kubota has received grants and honoraria for speakers bureau and has worked as a consultant for Taiho Pharmaceutical.Yukio Hosomi has received grants and/or honoraria for speakers bureau from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai Pharmaceutical, Eli Lilly, MSD, Novartis, Ono Pharmaceutical, Kyowa Hakko Kirin, and Taiho Pharmaceutical.Tsuneo Shimokawa has received grants from Astellas Pharma, AstraZeneca, Bristol-Myers Squibb, Chugai Pharmaceutical, Eli Lilly, Merck Serono, MSD, Ono Pharmaceutical, and Taiho Pharmaceutical.Hidetoshi Hayashi has received research support and/or honoraria for speakers bureau from AbbVie Inc., AC MEDICAL Inc., Astellas Pharma, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Eli Lilly, EPS Associates, GlaxoSmithKline, Japan Clinical Research Operations, Kyowa Hakko Kirin, Merck Serono, MSD, Novartis Pharma, Ono Pharmaceutical, Otsuka Pharmaceutical, PAREXEL International, Pfizer Japan, PPD-SNBL, Quintiles, Taiho Pharmaceutical, Takeda Pharmaceutical, Transnational Japan, and Yakult Honsha, and has worked as a consultant for AstraZeneca and Eli Lilly.Kazutaka Miyadera is an employee of Taiho Pharmaceutical Co., Ltd.Tomohide Tamura has received honoraria for speakers bureau from Boehringer Ingelheim, Bristol-Myers Squibb, Chugai Pharmaceutical, Eisai, Eli Lilly, Kyowa Hakko Kirin, MSD, Ono Pharmaceutical, Taiho Pharmaceutical, and Yakult Honsha.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.